Javascript must be enabled to continue!
Cognitive development in children with 22q11.2 deletion syndrome
View through CrossRef
BackgroundPeople with 22q11.2 deletion syndrome (velo-cardio-facial syndrome) have
a 30-fold risk of developing schizophrenia. In the general population the
schizophrenia phenotype includes a cognitive deficit and a decline in
academic performance preceding the first episode of psychosis in a
subgroup of patients. Findings of cross-sectional studies suggest that
cognitive abilities may decline over time in some children with 22q11.2
deletion syndrome. If confirmed longitudinally, this could indicate that
one or more genes within 22q11.2 are involved in cognitive decline.AimsTo assess longitudinally the change in IQ scores in children with 22q11.2
deletion syndrome.MethodSixty-nine children with the syndrome were cognitively assessed two or
three times at set ages 5.5 years, 7.5 years and 9.5 years.ResultsA mean significant decline of 9.7 Full Scale IQ points was found between
ages 5.5 years and 9.5 years. In addition to the overall relative decline
that occurred when results were scored according to age-specific IQ
norms, in 10 out of a group of 29 children an absolute decrease in
cognitive raw scores was found between ages 7.5 years and 9.5 years. The
decline was not associated with a change in behavioural measures.ConclusionsThe finding of cognitive decline can be only partly explained as the
result of ‘growing into deficit’; about a third of 29 children showed an
absolute loss of cognitive faculties. The results underline the
importance of early psychiatric screening in this population and indicate
that further study of the genes at the 22q11.2 locus may be relevant to
understanding the genetic basis of early cognitive deterioration.
Royal College of Psychiatrists
Title: Cognitive development in children with 22q11.2 deletion
syndrome
Description:
BackgroundPeople with 22q11.
2 deletion syndrome (velo-cardio-facial syndrome) have
a 30-fold risk of developing schizophrenia.
In the general population the
schizophrenia phenotype includes a cognitive deficit and a decline in
academic performance preceding the first episode of psychosis in a
subgroup of patients.
Findings of cross-sectional studies suggest that
cognitive abilities may decline over time in some children with 22q11.
2
deletion syndrome.
If confirmed longitudinally, this could indicate that
one or more genes within 22q11.
2 are involved in cognitive decline.
AimsTo assess longitudinally the change in IQ scores in children with 22q11.
2
deletion syndrome.
MethodSixty-nine children with the syndrome were cognitively assessed two or
three times at set ages 5.
5 years, 7.
5 years and 9.
5 years.
ResultsA mean significant decline of 9.
7 Full Scale IQ points was found between
ages 5.
5 years and 9.
5 years.
In addition to the overall relative decline
that occurred when results were scored according to age-specific IQ
norms, in 10 out of a group of 29 children an absolute decrease in
cognitive raw scores was found between ages 7.
5 years and 9.
5 years.
The
decline was not associated with a change in behavioural measures.
ConclusionsThe finding of cognitive decline can be only partly explained as the
result of ‘growing into deficit’; about a third of 29 children showed an
absolute loss of cognitive faculties.
The results underline the
importance of early psychiatric screening in this population and indicate
that further study of the genes at the 22q11.
2 locus may be relevant to
understanding the genetic basis of early cognitive deterioration.
Related Results
Noninvasive Prenatal Screening for 22q11.2 Deletion/Duplication Syndrome Using multiplex dPCR
Noninvasive Prenatal Screening for 22q11.2 Deletion/Duplication Syndrome Using multiplex dPCR
Abstract
Background
22q11.2 deletion/duplication syndrome has a high incidence in prenatal fetuses and cause variety of severe abnormalities. At present, screening for 22q...
Cardiovascular Malformations in CHARGE Syndrome with DiGeorge Phenotype: Two Case Reports
Cardiovascular Malformations in CHARGE Syndrome with DiGeorge Phenotype: Two Case Reports
Both CHARGE syndrome and DiGeorge anomaly are frequently accompanied by cardiovascular malformations. Some specific cardiovascular malformations such as interrupted aortic arch typ...
Schizophrenia and 22q11.2 Deletion Syndrome
Schizophrenia and 22q11.2 Deletion Syndrome
Abstract
22q11.2 deletion syndrome (22q11.2DS), also known as velocardiofacial syndrome, is the most frequent known interstitial deletion found ...
Novel 22q11.2 Deletions Detection Assay Using Gel Electrophoresis
Novel 22q11.2 Deletions Detection Assay Using Gel Electrophoresis
Background: 22q11.2 deletion syndrome (22q11.2DS), also known as Di-George/velocardiofacial syndrome is the most common chromosomal microdeletion and is frequently associated with ...
Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome
Abnormal cortical activation during response inhibition in 22q11.2 deletion syndrome
Abstract22q11.2 deletion syndrome (22q11.2DS) is a well‐known genetic risk factor for schizophrenia. The catechol‐O‐methyltransferase (COMT) gene falls within the 22q11.2 minimal c...
Mosaic 22q11.2 Deletion and Tetralogy of Fallot With Absent Pulmonary Valve
Mosaic 22q11.2 Deletion and Tetralogy of Fallot With Absent Pulmonary Valve
Chromosome 22q11.2 microdeletion is the most common microdeletion syndrome. Mosaic 22q11.2 deletions are very rare and only a few have been reported. We describe a case of a neonat...
Genotypic and phenotypic variability of 22q11.2 microdeletions – an institutional experience
Genotypic and phenotypic variability of 22q11.2 microdeletions – an institutional experience
<abstract>
<p>Patients with chromosome 22q11.2 deletion syndromes classically present with variable cardiac defects, parathyroid and thyroid gland hypoplasia, immunodef...
Neurodevelopmental outcome in 22q11.2 deletion syndrome and management
Neurodevelopmental outcome in 22q11.2 deletion syndrome and management
The 22q11.2 deletion syndrome (22q11.2 DS) places affected individuals at an increased risk for neurodevelopmental/cognitive, behavioral and social–emotional difficulties. Poor cog...

